ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) is a potent, selective inhibitor of soluble guanylyl cyclase (sGC) used as a research reagent in biochemical and cell-based studies. It blocks NO-activated sGC activity and has been reported to enhance the pro-apoptotic effects of cisplatin in certain cancer cell models. Supplied as a powder for preparation of stock solutions, it is intended for research use only.
- Potent, selective inhibitor of soluble guanylyl cyclase.
- Useful tool compound for studying nitric oxide-sGC signaling.
- Reported to enhance cisplatin-induced apoptosis in some cell models.
- Supplied as a powder suitable for preparing concentrated stock solutions.
- Stable with defined storage recommendations for powder and solutions.